Cargando…

Comparison of doublet and triplet therapies for metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis

BACKGROUND: The best choice of first-line treatment for metastatic hormone-sensitive prostate cancer (mHSPC) is unclear. We aimed to compare the effectiveness and safety determined in randomized clinical trials of doublet and triplet treatments for mHSPC. METHODS: Medline, Embase, Cochrane Central a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Li, Chunxing, Zhao, Zichen, Li, Xiaojian, Tang, Chong, Guan, Zhenpeng, Sun, Feng, Gu, Jin, Li, Ningchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028133/ https://www.ncbi.nlm.nih.gov/pubmed/36959793 http://dx.doi.org/10.3389/fonc.2023.1104242

Ejemplares similares

Systemic treatment of metastatic hormone-sensitive prostate cancer—upfront triplet versus doublet combination therapy
por: Oing, C., et al.
Publicado: (2023)

Advancements in the treatment of metastatic hormone-sensitive prostate cancer
por: Li, Hengping, et al.
Publicado: (2022)

Focusing with quadrupoles, doublets and triplets
por: Regenstreif, E
Publicado: (1964)

Back to the doublet-triplet splitting problem
por: Barbieri, Riccardo, et al.
Publicado: (1993)

Natural triplet-doublet splitting from supergravity
por: Kounnas, Costas, et al.
Publicado: (1983)

Discussion of Treatment Options for Metastatic Hormone Sensitive Prostate Cancer Patients
por: Sigurdson, Samantha S., et al.
Publicado: (2020)

Rescuing doublets into triplets in Pooh-Hydra geometry program
por: Yaffe, R
Publicado: (1974)

Singlet-doublet/triplet dark matter and neutrino masses
por: Fiaschi, Juri, et al.
Publicado: (2019)

A Cost-Effectiveness Analysis of Systemic Therapy for Metastatic Hormone-Sensitive Prostate Cancer
por: Sung, Winnie W. Y., et al.
Publicado: (2021)

Locally supersymmetric SO(10) with natural doublet/triplet splitting
por: Maalampi, J, et al.
Publicado: (1983)

Doublet-Triplet Splitting in Realistic Heterotic String Derived models
por: Faraggi, Alon E.
Publicado: (2001)

Insights into centriole geometry revealed by cryotomography of doublet and triplet centrioles
por: Greenan, Garrett A, et al.
Publicado: (2018)

Singlet and triplet to doublet energy transfer: improving organic light-emitting diodes with radicals
por: Li, Feng, et al.
Publicado: (2022)

Light colour-triplet Higgs is compatible with proton stability: an alternative approach to the doublet-triplet splitting problem
por: Dvali, Gia
Publicado: (1995)

Systemic triplet therapy for metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis
por: Jian, Tengteng, et al.
Publicado: (2022)

A Solution to the Doublet-Triplet Splitting Problem in the Type IIB Supergravity
por: Watari, T, et al.
Publicado: (2002)

HTA and Reimbursement Status of Metastatic Hormone‑Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review
por: Bencina, Goran, et al.
Publicado: (2023)

Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination Therapies
por: Wenzel, Mike, et al.
Publicado: (2021)

Remarks on the phase acceptance of a quadrupole multiplet application to the doublet and the symmetric triplet
por: Regenstreif, E
Publicado: (1969)

Focusing and magnification ratio adjustments with quadrupole triplets and doublets: Programme for the IBM 7090
por: Madsen, J H B
Publicado: (1964)

Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Propensity Score-Matched Analysis
por: Matsumura, Naoki, et al.
Publicado: (2021)

Spectral features of the tunneling-induced transparency and the Autler-Townes doublet and triplet in a triple quantum dot
por: Luo, Xiao-Qing, et al.
Publicado: (2018)

Detecting and monitoring bladder cancer with exfoliated cells in urine
por: Li, Nannan, et al.
Publicado: (2022)

Feasibility of apalutamide combined with androgen deprivation therapy and short-course low-dose prednisone in treating metastatic hormone-sensitive prostate cancer: a pilot randomized controlled trial
por: Yang, Dingyuan, et al.
Publicado: (2023)

Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: a propensity score matching analysis
por: Chen, Yonghe, et al.
Publicado: (2021)

Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A Systematic Review and Bayesian Network Meta-Analysis
por: Chen, Junru, et al.
Publicado: (2020)

Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
por: Li, Yi, et al.
Publicado: (2020)

BALD-2: a mutation affecting the formation of doublet and triplet sets of microtubules in Chlamydomonas reinhardtii
Publicado: (1975)

Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis
por: Parisi, Alessandro, et al.
Publicado: (2022)

Metastatic Prostate Cancer to the Urethra Masquerading as Urothelial Carcinoma
por: Zardawi, Ibrahim, et al.
Publicado: (2016)

Retrospective validation of bone risk stratification criteria for men with de novo metastatic hormone-naive prostate cancer in China
por: Zhang, Yang, et al.
Publicado: (2023)

Comparative Efficacy of Combined Radiotherapy, Systemic Therapy, and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Network Meta-Analysis and Systematic Review
por: Wang, Yuhan, et al.
Publicado: (2020)

Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd?
por: Davis, Ian D.
Publicado: (2022)

Triplet (FOLFOXIRI) Versus Doublet (FOLFOX or FOLFIRI) Regimen as First Line Treatment in Metastatic Colorectal Carcinoma, a Prospective Phase II, Randomized Controlled Trial
por: Khali, Khaled Ahmed, et al.
Publicado: (2022)

Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)—A Potential New Standard of Care
por: Mittal, Abhenil, et al.
Publicado: (2023)

Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy
por: Corsini, Christian, et al.
Publicado: (2023)

Role of the Anomalous $U(1)_A$ for the Solution of the Doublet-Triplet Splitting Problem via the Pseudo-Goldstone Mechanism
por: Dvali, G.R., et al.
Publicado: (1996)

Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
por: Onal, Cem
Publicado: (2019)

Clinical Significance of Mesenchymal Circulating Tumor Cells in Patients With Oligometastatic Hormone-Sensitive Prostate Cancer Who Underwent Cytoreductive Radical Prostatectomy
por: Yang, Guanjie, et al.
Publicado: (2022)

Toxicity Syndromes, Patient-Related Clinical Indicator of Toxicity Burden Induced by Intensive Triplet Chemotherapy-Based Regimens in Gastrointestinal Cancers With Metastatic Disease
por: Bruera, Gemma, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uv5anmbqpctisluh7obp9u6gt7